MSB 7.69% $1.19 mesoblast limited

Regenerative Medicine and Cell Therapies Virtual Event, page-41

  1. 309 Posts.
    lightbulb Created with Sketch. 103
    Our current trial based on 2D manufacturing process cell if in future we are scale up manufacturing using 3D Bioreactor then do we require separate trial for produce cell from 3D Bioreactor like efficacy, quality??
    Last edited by Sam_123: 18/09/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.